Who owns PLIANT THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PLRX from SEC Form 13F filings across 86 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 86 institutions disclosed 48.1M shares of PLIANT THERAPEUTICS, INC. worth $54.8M — about 77.7% of shares outstanding; the largest disclosed holder is TANG CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
86
13F holders
$54.8M
value, 2026 filers
77.7%
of shares outstanding (48.1M sh)
9
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PLRX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLC | 6.1M | $7.0M | 0.3% | 9.9% | 0.0% |
| 2 | ADAR1 Capital Management, LLC | 5.5M | $6.3M | 0.3% | 8.9% | +113.1% |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 2.4M | $2.8M | 0.0% | 3.9% | +4.2% |
| 4 | ACADIAN ASSET MANAGEMENT LLC | 2.4M | $2.7M | 0.0% | 3.9% | 0.0% |
| 5 | TWO SIGMA INVESTMENTS, LP | 2.3M | $2.6M | 0.0% | 3.7% | +0.4% |
| 6 | CITADEL ADVISORS LLC | 2.1M | $2.4M | 0.0% | 3.5% | -33.6% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 2.0M | $2.3M | 0.0% | 3.3% | +10.6% |
| 8 | Monaco Asset Management SAM | 1.9M | $2.2M | 0.2% | 3.1% | 0.0% |
| 9 | Lynx1 Capital Management LPNEW | 1.8M | $2.0M | 0.2% | 2.9% | new |
| 10 | BML Capital Management, LLC | 1.5M | $1.8M | 1.0% | 2.5% | 0.0% |
| 11 | Prosight Management, LP | 1.4M | $1.6M | 0.3% | 2.2% | -17.8% |
| 12 | Peapod Lane Capital LLC | 1.3M | $1.5M | 1.0% | 2.1% | +1.6% |
| 13 | Woodline Partners LP | 1.3M | $1.5M | 0.0% | 2.1% | -22.2% |
| 14 | BlackRock, Inc. | 1.2M | $1.3M | 0.0% | 1.9% | +5.0% |
| 15 | Ikarian Capital, LLCNEW | 1.0M | $1.1M | 0.1% | 1.6% | new |
| 16 | Eversept Partners, LP | 891,425 | $1.0M | 0.1% | 1.4% | 0.0% |
| 17 | MARSHALL WACE, LLP | 835,124 | $952,041 | 0.0% | 1.3% | -16.1% |
| 18 | Redmile Group, LLC | 772,126 | $880,224 | 0.1% | 1.2% | 0.0% |
| 19 | JPMORGAN CHASE & CO | 681,647 | $783,894 | 0.0% | 1.1% | -20.9% |
| 20 | JACOBS LEVY EQUITY MANAGEMENT, INC | 643,120 | $733,157 | 0.0% | 1% | -10.5% |
| 21 | GEODE CAPITAL MANAGEMENT, LLC | 578,577 | $659,954 | 0.0% | 0.9% | +38.7% |
| 22 | UBS Group AG | 571,760 | $651,806 | 0.0% | 0.9% | -46.0% |
| 23 | MILLENNIUM MANAGEMENT LLC | 559,447 | $637,770 | 0.0% | 0.9% | -52.6% |
| 24 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 553,630 | $631,138 | 0.0% | 0.9% | 0.0% |
| 25 | Connor, Clark & Lunn Investment Management Ltd. | 536,081 | $611,132 | 0.0% | 0.9% | +3.6% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.